HLA HETEROZYGOSITY IN INSULIN-DEPENDENT DIABETES IS MOST FREQUENT AT THE DQ LOCUS

被引:20
作者
MICHELSEN, B
WASSMUTH, R
LUDVIGSSON, J
LERNMARK, A
NEPOM, GT
FISHER, L
机构
[1] UNIV WASHINGTON, DEPT MED, RG-20, SEATTLE, WA 98195 USA
[2] UNIV WASHINGTON, DEPT BIOSTAT, SEATTLE, WA 98195 USA
[3] HAGEDORN RES LAB, DK-2820 GENTOFTE, DENMARK
[4] UNIV LINKOPING, REG HOSP, DEPT PEDIAT, LINKOPING, SWEDEN
[5] VIRGINIA MASON RES CTR, SEATTLE, WA 98101 USA
关键词
D O I
10.1111/j.1365-3083.1990.tb02786.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Restriction fragment length polymorphism using an HLA‐DQ β‐chain genomic probe showed that 63 children with insulin‐dependent (type 1) diabetes mellitus (IDDM) were all (100%) positive for the BamH1 fragments 12 kb and/or 4 kb compared to 98% (62/63) for HLA‐DR3 and/or 4 and 75% (47/63) for HLA‐B8 and/or 15. The 36 (56%) DR3‐positive children were all 4‐kb‐positive; however, a total of 44 (70%) children were 4‐kb‐positive (P < 0.02). The 55 (87%) DR4‐positive children were all 12‐kb‐positive, but a total of 56 (89%) were 12‐kb‐positive (NS), The heterozygosity at the HLA region increased from 11/63 (18%) for HLA‐B8/15 to 29/63 (46%) for HLA‐DR3/4 (P < 0,0004) and to 37/63 (59%) for the HLA‐DQ 4 kb/12 kb fragments (P < 0.02). The test of an equal probability ofa positive result under the adjacent pair of tests indicates that the increased risk of developing IDDM in association with HLA‐DQ is to a great extent due to heterozygosity at this locus. There were no differences between the 4 kb/12 kb and the DR3/4‐positive IDDM children with respect to fasting or meal‐stimulated C peptide, insulin requirement, or levels of insulin antibodies formed during the first 12 months of insulin therapy. Our results support the hypothesis that HLA‐DQ is closely associated with an increased risk of childhood IDDM, and when typed for at this locus parameters of the clinical course were homogeneous, suggesting that factors other than HLA‐DQ may determine previously observed differences between IDDM children in clinical or functional parameters. Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:405 / 413
页数:9
相关论文
共 56 条
[1]   HLA RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS ASSOCIATED WITH INSULIN-DEPENDENT DIABETES-MELLITUS AND THE SERONEGATIVE SPONDYLOARTHROPATHIES [J].
ACTON, RT ;
HODGE, TW ;
MCDANIEL, DO ;
REVEILLE, JD ;
NAPIERLITTRELL, M ;
BARGER, BO .
BIOSCIENCE REPORTS, 1985, 5 (10-11) :815-829
[2]  
AMAR A, 1987, J IMMUNOL, V138, P3986
[3]   HLA-DQ SYSTEM AND INSULIN-DEPENDENT DIABETES-MELLITUS IN JAPANESE - DOES IT CONTRIBUTE TO THE DEVELOPMENT OF IDDM AS IT DOES IN CAUCASIANS [J].
APARICIO, JMR ;
WAKISAKA, A ;
TAKADA, A ;
MATSUURA, N ;
AIZAWA, M .
IMMUNOGENETICS, 1988, 28 (04) :240-246
[4]   CORRELATES OF INSULIN-ANTIBODIES IN NEWLY DIAGNOSED CHILDREN WITH INSULIN-DEPENDENT DIABETES BEFORE INSULIN THERAPY [J].
ARSLANIAN, SA ;
BECKER, DJ ;
RABIN, B ;
ATCHISON, R ;
EBERHARDT, M ;
CAVENDER, D ;
DORMAN, J ;
DRASH, AL .
DIABETES, 1985, 34 (09) :926-930
[5]   ARE INSULIN AUTOANTIBODIES MARKERS FOR INSULIN-DEPENDENT DIABETES-MELLITUS [J].
ATKINSON, MA ;
MACLAREN, NK ;
RILEY, WJ ;
WINTER, WE ;
FISK, DD ;
SPILLAR, RP .
DIABETES, 1986, 35 (08) :894-898
[6]   ANTIBODIES TO A 64,000 MR HUMAN ISLET CELL ANTIGEN PRECEDE THE CLINICAL ONSET OF INSULIN-DEPENDENT DIABETES [J].
BAEKKESKOV, S ;
LANDIN, M ;
KRISTENSEN, JK ;
SRIKANTA, S ;
BRUINING, GJ ;
MANDRUPPOULSEN, T ;
DEBEAUFORT, C ;
SOELDNER, JS ;
EISENBARTH, G ;
LINDGREN, F ;
SUNDQUIST, G ;
LERNMARK, A .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (03) :926-934
[7]   DIABETES IN IDENTICAL-TWINS - A STUDY OF 200 PAIRS [J].
BARNETT, AH ;
EFF, C ;
LESLIE, RDG ;
PYKE, DA .
DIABETOLOGIA, 1981, 20 (02) :87-93
[8]   HLA-DR ALLOGENOTYPING USING EXON-SPECIFIC CDNA PROBES AND APPLICATION OF RAPID MINIGEL METHODS [J].
BIDWELL, JL ;
JARROLD, EA .
MOLECULAR IMMUNOLOGY, 1986, 23 (10) :1111-1116
[9]  
BOHME J, 1986, J IMMUNOL, V137, P941
[10]  
BOTTAZZO GF, 1981, CLIN IMMUNOL ALLERGY, V1, P139